Navigation Links
CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
Date:10/6/2009

SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a new clinical and medical products corporation, has received No. 1 rankings by independent market research firms for two of the corporation's key brands. CareFusion's Pyxis® technologies were again named number one in user satisfaction ratings in MD Buyline's 2009 third quarter report (July through September) for the third consecutive quarter; and CareFusion's MedMined(TM) Services received the annual top ranking for infection surveillance technology providers by KLAS, published in August 2009.

"These rankings reflect our commitment to deliver superior customer service and innovative medical technologies that are clinically proven to improve patient care," said Dave Schlotterbeck, chairman and chief executive officer of CareFusion. "While CareFusion is a new company, we have a long history of helping hospitals and medical facilities improve health care delivery in terms of effectiveness, cost efficiencies and, most importantly, patient safety."

MD Buyline collects technology evaluations from health care providers and tallies the scores based on a 12-month rolling average score. KLAS' ratings are based on the overall performance calculated from individual scores for each of 40 criteria, consisting of 28 performance indicators and 12 business indicators based on a 100-point scale.

CareFusion's Pyxis® technologies for managing medications and supplies have been shown to reduce supply costs by 50 percent(1) and help to protect 1.5 million patients annually from medication errors(2). Additionally, CareFusion estimates that its MedMined(TM) Services has the potential to help hospitals save 6,800 lives and $1 billion in health care costs annually by helping to identify at-risk patients and ways to reduce health care-acquired infections (HAIs)(3).

Pyxis® Technologies will be highlighted at the upcoming Managing Today's OR Suite (MTORS) Conference and Exhibition in Las Vegas, Nev., from October 7-8, 2009.

About the MD Buyline and KLAS Rankings

MD Buyline provides the most comprehensive database of information on health care products. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies.

KLAS is a research firm specializing in monitoring and reporting the performance of health care vendors. KLAS' mission is to improve delivery of care, by independently measuring vendor performance for the benefit of health care providers, consultants, investors, and vendors. The 2009 KLAS report, Infection Control: Improving Patient Care and Reimbursements, highlights the recent growth and leading vendors in the market for infection control software, which analyzes data from various hospital departments to identify potential infections.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

    (1) St. John's Medical Center. CareFusion, 2007.
    (2) Preventing Medication Errors: Quality Chasm Series. Institute of
        Medicine, July 2006.
    (3) Projection based on aggregate internal analysis of 174 MedMined
        services clients' performance between August 2006 and October 2008.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
2. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
5. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
6. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
8. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
9. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
10. Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
11. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/28/2016)... , ... May 28, 2016 , ... After a year and a half of planning ... an extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, ... country and the United Kingdom came together to explore the many pathways individuals use to ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ... that it has been recognized as one of the best small businesses for new ... as one of nine small businesses providing progressive benefits to new parents on the ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... 26, 2016 , ... Intalere, the healthcare industry leader in ... inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May 17-20, ... America’s healthcare providers. , The conference was highlighted by the announcement of the ...
Breaking Medicine News(10 mins):